# Vasopressors {#sec-vasopressors}

Vasopressors are drugs that predominantly constrict peripheral vasculature, causing a:

:::column-margin
Similar to @sec-inotropes, many vasopressors have inotropic effects. Unlike inotropes however, there are s.
:::

* Primary ↑ in SVR, causing a secondary ↑ in MAP
* Primary ↑ venous tone which ↓ venous compliance and ↑ stressed volume, causing a secondary ↑ in preload

:::column-margin
Venous blood volume can be divided conceptually into:

* **Unstressed volume**\
Does not exert meaningful pressure on the walls of the vasculature, and so does not contribute to MSFP. Contributes ~85% of total vascular volume under normal circumstances.
* **Stressed volume**\
Exerts pressure on the walls of the vasculature and therefore produces MSFP.
:::


## Indications

## Contraindications


+---------------+---------------+---------------------------------+--------------------------------------+
| Drug          | Noradrenaline | Vasopressin                     | Methylene Blue                       |
+===============+===============+=================================+======================================+
| Overview      |               | Endogenous nonapeptide\         |                                      |
|               |               | Acts on V~1~ and V~2~ receptors |                                      |
+---------------+---------------+---------------------------------+--------------------------------------+
|               |               | * Not a catecholamine\          | * Mesenteric vasoconstriction        |
|               |               | Works synergistically.          | * Coronary vasoconstriction\         |
|               |               | * Not affected by acidosis      | May lead to ischaemia.               |
|               |               | * Not pro-arrhythmic            | * Possibly ↑ microcirculatory change |
|               |               | * Fluid retention               | * Hyponatraemia                      |
+---------------+---------------+---------------------------------+--------------------------------------+
| Disadvantages |               |                                 | * MAO Inhibition                     |
+---------------+---------------+---------------------------------+--------------------------------------+


## Comparison

## Equipment

## Technique

## Complications

## Key Studies

* VAAST
* VANISH


---

## References

1. Bersten, A. D., & Handy, J. M. (2018). Oh’s Intensive Care Manual. Elsevier Gezondheidszorg.
